Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for Pim 1
Most Correlated Studies
- Cord blood mononuclear cells depleted of PIM kinases under Th1 or Th2 polarizing conditions
- Multiple myeloma MM.1S and U266 cells treated with PIM2 kinase inhibitor JP11646
- Age-dependent differences in gene expression and rotenone response of dermal fibroblasts
- Cardiac interstitial cells from heart failure patients with PIM1 overexpression
- Effect of IL3 on mRNA stability in myeloblasts
Most Relevant Literature
- Discovery of 5-Azaindazole (GNE-955) as a Potent Pan-Pim Inhibitor with Optimized Bioavailability.
- Discovery of N-substituted 7-azaindoles as Pan-PIM kinase inhibitors - Lead series identification - …
- Targeting Pim kinases for cancer treatment: opportunities and challenges.
- Expression and function of PIM kinases in osteosarcoma.
- The discovery of novel 3-(pyrazin-2-yl)-1H-indazoles as potent pan-Pim kinase inhibitors.
Most Relevant Clinical Trials
- Randomised Evaluation of COVID-19 Therapy (RECOVERY) in Children With PIMS-TS in Switzerland (SWISSP…
- PIM Incidence in Older Cardiovascular Patients During COVID-19 Pandemics
- Physiological Intermolecular Modification Spectroscopy (PIMS) in Ulcerative Colitis With Golimumab
- PIM 2.0: Patient Aligned Care Team (PACT) Intensive Management (PIM) Project
- Prognostic Potential of Cell Surface Markers and Pim Kinases in Multiple Myeloma
